Zicong Yang

Zicong Yang

Auto-generated profile, based on publicly available information

Zicong Yang

Department of Cardiology The People's Hospital of Guangxi Zhuang Autonomous Region Nanning 530021 China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2020 in Aging
Verified
Journal Article
Open access
JYJing Ye
Jing Ye
YWYuan Wang
Yuan Wang
ZWZhen Wang
Zhen Wang
LLLing Liu
Ling Liu
ZYZicong Yang
Zicong Yang
JWJun Wan
Jun Wan
Our previous studies have demonstrated that interleukin-12p35 knockout (IL-12p35 KO) regulates the progression of various cardiovascular diseases, such as acute cardiac injury and hypertension. The aims of this study were to investigate whether IL-12p35 KO affects aging-related cardiac remodeling and to explore the possible mechanisms. First, the effects of IL-12p35 KO on heart structure and function were detected, and the results showed that IL-12p35 KO exacerbated cardiac remodeling and increased cardiac senescence-related protein levels in aged mice. In addition, whether IL-12p35 KO regulates cardiac senescence-related protein expression, cardiac mitochondrial dysfunction and cardiomyocyte apoptosis was also investigated. IL-12p35 KO increased mitochondrial calcium fluorescence intensity and ROS fluorescence intensity, while it reduced mitochondrial membrane potential. Furthermore, reduced mitochondrial complex (I-IV) activity and ATP levels and increased apoptosis-inducing factor (AIF)-related cardiomyocyte apoptosis were observed in aged IL-12p35 KO mice compared with wild-type mice. Our results demonstrate that aging is aggravated by IL-12p35 KO and that the mechanism may be related to exacerbation of mitochondrial dysfunction and AIF-related cardiomyocyte apoptosis.

3 March 2020 in Cell Biology International
Verified
Journal Article
Open access
PDF file
DXDan Xiao
Dan Xiao
YZYingying Zhan
Yingying Zhan
ZYZicong Yang
Zicong Yang
CFCao Fang
Cao Fang
LLLing Liu
Ling Liu
YLYingzhong Lin
Yingzhong Lin
Previous studies have demonstrated that interleukins (ILs) are closely associated with doxorubicin (DOX)‐induced cardiac injury. IL‐5 is an important member of the IL family, and this study was performed to investigate whether IL‐5 affects DOX‐induced cardiac injury and its underlying mechanisms. The cardiac IL‐5 expression was first detected and the results showed that cardiac IL‐5 levels were significantly lower in DOX‐treated mice, and IL‐5 was mainly derived from cardiac macrophage (Mø). In addition, some DOX‐treated mice received an injection of anti‐IL‐5‐neutralizing antibody (nAb), and we found that treatment with a mouse anti‐IL‐5 nAb significantly upregulated the levels of myocardial injury markers, aggravated cardiac dysfunction, increased M1 macrophage (Mø1) and decreased M2 macrophage (Mø2) differentiation, and promoted apoptotic marker expression. Furthermore, the effect of mouse IL‐5 nAb on DOX‐induced Mø differentiation and its role on mouse cardiomyocyte (MCM) cells apoptosis were detected in vitro, and the results exhibited that mouse IL‐5 nAb promoted Mø1 differentiation but inhibited Mø2 differentiation in vitro and alleviated apoptosis in MCM cells. Our results found a mouse anti‐IL‐5 nAb‐aggravated DOX‐induced cardiac injury and dysfunction by alleviating the inflammatory response and myocardial cell apoptosis.

1 January 2019 in Canadian Journal of Cardiology
Verified
Journal Article
Open access
AJAmer M Johri
Amer M Johri
PPPaul Poirier
Paul Poirier
PDPaul Dorian
Paul Dorian
AFAnne Fournier
Anne Fournier
JGJack M. Goodman
Jack M. Goodman
PMPierre Mongeon
Pierre Mongeon